Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti Obesity Agent”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Not applicableActive Not RecruitingNCT05346575
What this trial is testing

TOTAL: A Multisite RCT

Who this might be right for
ObesityOverweight
VA Office of Research and Development 440
Large-scale testing (Phase 3)Study completedNCT03336086
What this trial is testing

Effect of Weight Reduction on Immunity

Who this might be right for
LymphocytesWeight LossViral Diseases+2 more
Shiraz University of Medical Sciences 29
Testing effectiveness (Phase 2)WithdrawnNCT00735683
What this trial is testing

A Short-Term Study to Examine the Effects of ATHX-105 Phosphate on Weight Loss and Safety

Who this might be right for
Obesity
Healios K.K.
Testing effectiveness (Phase 2)Study completedNCT04095104
What this trial is testing

Adjunct Phentermine + Topiramate After Bariatric Surgery in 12-24 Year Olds

Who this might be right for
Obesity, MorbidBariatric SurgeryAdolescent+2 more
University of Colorado, Denver 13
Very early researchLooking for participantsNCT06171152
What this trial is testing

Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues

Who this might be right for
Multiple SclerosisLong COVIDLong Covid19+4 more
University of Chicago 30
Large-scale testing (Phase 3)Study completedNCT00532779
What this trial is testing

The Safety and Efficacy of Two Doses of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects

Who this might be right for
ObesityOverweight
Orexigen Therapeutics, Inc 1,742
Not applicableLooking for participantsNCT06431308
What this trial is testing

Nutritional Therapy to Incretin-based Anti-obesity Medications in the Management of Gastrointestinal Adverse Events

Who this might be right for
Obesity; Drug
Ariel University 120
Testing effectiveness (Phase 2)Study completedNCT00822705
What this trial is testing

Inhibition of Food Intake in Response to Oral GLP-1 and Peptide YY3-36

Who this might be right for
Anti Obesity Agent
University Hospital, Basel, Switzerland 16
Testing effectiveness (Phase 2)Study completedNCT00650806
What this trial is testing

The Safety and Effectiveness of Canagliflozin (JNJ-28431754) in Promoting Weight Loss in Overweight and Obese Patients Who do Not Have Diabetes

Who this might be right for
Obesity
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 376
Not applicableNot Yet RecruitingNCT07387796
What this trial is testing

Clinical and Neurobehavioral Changes With Weight Loss Drug Discontinuation and Reinitiation

Who this might be right for
Drug DiscontinuationSubstance Use DisordersEating Behavior Changes+1 more
The University of Texas at Dallas 40
Post-approval studies (Phase 4)Study completedNCT01090141
What this trial is testing

Drug Concentration Analysis of Micafungin in Overweight, Obese, and Extremely Obese Volunteers

Who this might be right for
ObesityNutrition DisordersOverweight
University of Texas Southwestern Medical Center 36
Post-approval studies (Phase 4)Looking for participantsNCT05975580
What this trial is testing

Pharmacotherapy in Conjunction With Lifestyle Counseling for Management of Weight Regain After Bariatric Surgery

Who this might be right for
Obesity
University of California, Irvine 120
Early research (Phase 1)Study completedNCT01979380
What this trial is testing

Phase I Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics of KD101 in Healthy Male Subjects

Who this might be right for
Drug Toxicity
Kwang Dong Pharmaceutical co., ltd. 40
Testing effectiveness (Phase 2)Study completedNCT01765608
What this trial is testing

Zonisamide for the Treatment of Obstructive Sleep Apnea in Overweight/Obese Patients

Who this might be right for
Sleep ApneaObstructive Sleep ApneaObesity
Göteborg University 50
Not applicableStudy completedNCT00108524
What this trial is testing

A Low-Carbohydrate, Ketogenic Diet Versus Orlistat for Weight Loss

Who this might be right for
Diabetes MellitusObesity
US Department of Veterans Affairs 146
Testing effectiveness (Phase 2)Study completedNCT02597101
What this trial is testing

Anti-Inflammatory Small Drug Adjunctive Therapy for Type 2 Diabetes

Who this might be right for
Type 2 Diabetes MellitusInsulin Resistance
Nick Giannoukakis, PhD 14
Not applicableUnknownNCT05069298
What this trial is testing

Effect of Silibinin(A) as a Potential Anti-obesity Agent

Who this might be right for
Overweight and ObesityHypercholesterolemiaHypertriglyceridemia
Universidad Católica San Antonio de Murcia 60
Post-approval studies (Phase 4)Study completedNCT00044187
What this trial is testing

The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder

Who this might be right for
SchizophreniaPsychotic DisordersBipolar Disorder
Eli Lilly and Company 130
Testing effectiveness (Phase 2)Study completedNCT05121441
What this trial is testing

Study to Evaluate ARD-101 in Adults With Obesity

Who this might be right for
Obesity
Aardvark Therapeutics, Inc. 20
Large-scale testing (Phase 3)Ended earlyNCT00478595
What this trial is testing

Japanese Study With Rimonabant in Obese Type 2 Diabetic Patients With Oral Anti-diabetic Drug

Who this might be right for
ObesityDiabetes Mellitus Type 2
Sanofi 458
Load More Results